Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 10 (October)

1. Should completely intracorporeal anastomosis be considered in obese patients who undergo laparoscopic colectomy for benign or malignant disease of the colon?
   Surgery, 140(4): 675-82; discussion 682-3. [Abstract] [Full-text]
2. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
   Int J Radiat Oncol Biol Phys, 66(3): 762-71. [Abstract] [Full-text]
3. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.
   Int J Cancer, 119(10): 2272-8. [Abstract] [Full-text]
4. Anticancer effects of amooranin in human colon carcinoma cell line in vitro and in nude mice xenografts.
   Int J Cancer, 119(10): 2443-54. [Abstract] [Full-text]
5. Molecular determinants of irinotecan efficacy.
   Int J Cancer, 119(10): 2435-42. [Abstract] [Full-text]
6. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
   Int J Radiat Oncol Biol Phys, 66(3): 669-73. [Abstract] [Full-text]
7. The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery.
   Br J Cancer, 95(7): 928-33. [Abstract] [Full-text]
8. Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology.
   Br J Cancer, 95(7): 889-95. [Abstract] [Full-text]
9. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists.
   Br J Cancer, 95(7): 841-7. [Abstract] [Full-text]
10. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer.
    Br J Cancer, 95(7): 921-7. [Abstract] [Full-text]
11. Computed tomographic colonography (CTC) performance: one-year clinical follow-up.
    Clin Radiol, 61(11): 932-6. [Abstract] [Full-text]
12. Diagnostic value of multidetector row CT in rectal cancer staging: comparison of multiplanar and axial images with histopathology.
    Clin Radiol, 61(11): 924-31. [Abstract] [Full-text]
13. Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience.
    Clin Radiol, 61(11): 916-23. [Abstract] [Full-text]
14. Clinical application of pharmacogenetics in gastrointestinal diseases.
    Expert Opin Pharmacother, 7(14): 1857-69. [Abstract] [Full-text]
15. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Am J Clin Oncol, 29(5): 435-41. [Abstract] [Full-text]
16. Preoperative radiotherapy alone or combined with chemotherapy followed by transanal excision for rectal adenocarcinoma.
    Am J Clin Oncol, 29(5): 430-4. [Abstract] [Full-text]
17. Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer.
    AAPS PharmSciTech, 7(3): 74. [Abstract] [Full-text]
18. Stage II colon cancer prognosis prediction by tumor gene expression profiling.
    J Clin Oncol, 24(29): 4685-91. [Abstract] [Full-text]
19. Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes.
    Clin Genet, 70(5): 388-95. [Abstract] [Full-text]
20. High-resolution analysis of HLA class I alterations in colorectal cancer.
    BMC Cancer, 6: 233. [Abstract] [Full-text]
21. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery.
    Br J Anaesth, 97(5): 640-6. [Abstract] [Full-text]
22. Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers.
    Cancer Sci, 97(11): 1147-54. [Abstract] [Full-text]
23. Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.
    Cancer Sci, 97(11): 1226-35. [Abstract] [Full-text]
24. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study.
    BMJ, 333(7572): 779. [Abstract] [Full-text]
25. The consensus coding sequences of human breast and colorectal cancers.
    Science, 314(5797): 268-74. [Abstract] [Full-text]
26. Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers.
    Genes Chromosomes Cancer, 45(12): 1143-54. [Abstract] [Full-text]
27. A de novo MLH1 germ line mutation in a 31-year-old colorectal cancer patient.
    Genes Chromosomes Cancer, 45(12): 1106-10. [Abstract] [Full-text]
28. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    J Natl Cancer Inst, 98(20): 1494-500. [Abstract] [Full-text]
29. Population-based assessment of the surgical management of locally advanced colorectal cancer.
    J Natl Cancer Inst, 98(20): 1474-81. [Abstract] [Full-text]
30. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum.
    Gut, 55(11): 1592-7. [Abstract] [Full-text]
31. ESE-3 transcription factor is involved in the expression of death receptor (DR)-5 through putative Ets sites.
    Biochem Biophys Res Commun, 350(3): 736-41. [Abstract] [Full-text]
32. Cytotoxic activity of violacein in human colon cancer cells.
    Toxicol In Vitro, 20(8): 1514-21. [Abstract] [Full-text]
33. Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
    J Clin Oncol, 24(30): 4914-21. [Abstract] [Full-text]
34. Panitumumab in colon cancer: a review and summary of ongoing trials.
    Expert Opin Biol Ther, 6(11): 1229-35. [Abstract] [Full-text]
35. Recent developments in colorectal cancer treatment by monoclonal antibodies.
    Expert Opin Biol Ther, 6(11): 1175-92. [Abstract] [Full-text]
36. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
    Hum Pathol, 37(11): 1498-502. [Abstract] [Full-text]
37. Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers.
    Radiology, 241(2): 417-25. [Abstract] [Full-text]
38. Loss of extracellular E-cadherin in the normal mucosa of duodenum and colon of patients with familial adenomatous polyposis.
    Hum Pathol, 37(11): 1389-99. [Abstract] [Full-text]
39. CD97 overexpression in tumor cells at the invasion front in colorectal cancer (CC) is independently regulated of the canonical Wnt pathway.
    Mol Carcinog, 45(11): 881-6. [Abstract] [Full-text]
40. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients.
    Mol Carcinog, 45(11): 833-40. [Abstract] [Full-text]
41. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
    Clin Cancer Res, 12(20): 5951-9. [Abstract] [Full-text]
42. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies.
    Int J Cancer, 119(11): 2657-64. [Abstract] [Full-text]
43. Mitochondrial microsatellite instability of colorectal cancer stroma.
    Int J Cancer, 119(11): 2607-11. [Abstract] [Full-text]
44. Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung.
    Int J Cancer, 119(11): 2603-6. [Abstract] [Full-text]
45. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.
    Int J Cancer, 119(11): 2567-74. [Abstract] [Full-text]
46. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia.
    Int J Cancer, 119(11): 2651-6. [Abstract] [Full-text]
47. Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases.
    Oncogene, 25(50): 6563-73. [Abstract] [Full-text]
48. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
    Oncogene, 25(50): 6628-36. [Abstract] [Full-text]
49. Targeted gene-expression analysis by genome-controlled reverse transcription-PCR.
    Clin Chem, 52(11): 1988-96. [Abstract] [Full-text]
50. Cancer risk in endoscopically unresectable colon polyps.
    Am J Surg, 192(5): 644-8. [Abstract] [Full-text]
51. Duodenal carcinoma in MUTYH-associated polyposis.
    J Clin Pathol, 59(11): 1212-5. [Abstract] [Full-text]
52. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk.
    J Clin Oncol, 24(31): 5010-6. [Abstract] [Full-text]
53. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    J Clin Oncol, 24(31): 4998-5004. [Abstract] [Full-text]
54. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    J Clin Oncol, 24(31): 4983-90. [Abstract] [Full-text]
55. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
    J Clin Oncol, 24(31): 4976-82. [Abstract] [Full-text]
56. Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer.
    BMC Cancer, 6: 250. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.